Grove Nanomaterials Ltd

Quantum Physics to Medical Diagnostics.

Grove Nanomaterials, a Swansea Uni spinout launched in March 2023, is developing innovative home diagnostic tests using quantum gold nanoparticles. The company’s technology enables multiplex lateral flow tests for allergies, kidney disease, and cancer. Backed by a raft of patents, Grove's tunable nanoparticles offer clear, multi-disease testing. With proofs of principle established, Grove’s new nanomaterials factory and test lab opened in Cardiff (Spark) in 2024, Grove is ready to scale operations in 2025 generating revenue from 2026.

Currently raising funds via SETsquared Partnership.

Healthcare Medtech

Website

Financials

Raising:	£500,000
Deadline:	18-09-2025

Learn More

The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Investors should carry out their own due diligence and take professional advice where necessary.

We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.

If you'd like your events, opportunities and news listed here please join free as an organisation.